Clinical trial ‘High Throughput Centres’ could help UK compete post-Brexit

The EU is set to introduce a major update to clinical trials practice in 2019 and 2020 – the Clinical Trials Regulation (CTR).

‘Streamlined’ medicines regulation promised in ‘No Deal’ Brexit scenario

The government has confirmed that the existing 2004 Regulations will remain in force, but that its long-awaiting updated version, the new EU Clinical Trials Regulation (. CTR. ) 536/2014 will not ... CTR. without delay when it does come into force,

Can a post-Brexit UK stay aligned with Europe on clinical research?

CTR but also other issues such as impacts on trade, access to new medicines, data, funding and the workforce. ... The UK government should continue to seek full regulatory alignment with the [CTR],” says CRUK’s report.

Promoting off-label use: where to draw the line?

This can be seen in the court's case law, which held that 'off-label prescribing is the sole responsibility of the prescribing physicians' (CTRS judgment) in 'individual situations justified by

Nine positive opinions for new drugs at CHMP meeting

Laboratoires CTRS bagged a positive opinion for Neofordex, a 40mg tablet formulation of the corticosteroid dexamethasone, as a treatment for multiple myeloma.

Mastering data protection in the pharma industry

GDPR and the Clinical Trials Regulation (CTR) (which entered into force in 2014 and is expected to become applicable in 2020). ... The CTR’s objective is to harmonise the rules for conducting clinical trials throughout the EU.

Retaining reader value in plain language summaries of clinical studies

Regulation 536/2014 (EU CTR Article 37).

Digital

Drug pricing

Medical education

Using contextual moments in marketing

The advantage is a more interested audience, more engaged with your advertisement, meaning higher CTR% and more conversions.